Joint Replacement Reveals Protein’s Limits for Muscle Strength

Protein can help protect muscle around joint replacement surgery. It cannot, by itself, restore the strength needed to stand, climb stairs, or trust a newly replaced knee. That distinction is the useful lesson in a 2025 meta-analysis of perioperative protein and amino acid trials: supplementation preserved muscle mass, with standardized mean differences of 0.69 to 1.04, while pooled grip and quadriceps strength outcomes remained non-significant.

For anyone trying to prevent sarcopenia, this is less a disappointment than a boundary marker. Amino acids supply raw material for muscle protein synthesis. Strength also depends on neural recruitment, coordination, pain, confidence, and mechanical loading. Surgery temporarily removes much of that loading. A supplement shake cannot perform a leg press on your behalf.

What the arthroplasty trials found

The 2025 systematic review and meta-analysis by Khani et al. pooled 19 randomized controlled trials involving 903 people undergoing total joint arthroplasty. Fourteen trials used oral supplements and five used intravenous amino acid delivery; six specifically used essential amino acid formulations. Across the pooled studies, protein or amino acid supplementation favored preservation of muscle mass, with standardized mean differences ranging from 0.69 to 1.04.

Those are medium-to-large standardized effects by conventional benchmarks, but they do not translate neatly into a number of pounds of muscle saved or a guarantee of better daily function. The review did not provide a single clinically portable absolute difference in the summary evidence here, and its follow-up periods varied dramatically: a mean of 55.2 days with a standard deviation of 84.9 days, ranging from one day to one year. A result measured during acute bed rest does not answer the same question as one measured months into rehabilitation.

The functional finding matters most: pooled quadriceps strength and grip strength did not improve significantly. Grip strength is also an imperfect stand-in for recovery after lower-limb surgery. A null grip result cannot prove that the operated leg received no benefit. Still, the combined pattern is hard to ignore: preserving tissue and restoring force are separate jobs.

Protein can reduce the nutritional damage of disuse. It does not replace the mechanical and neural work of rehabilitation.

Why surgery accelerates a sarcopenia problem

Age-related muscle loss usually unfolds slowly. The review by Hardy et al. describes chronic age-related loss at roughly 0.5% to 1% of muscle mass per year, while lower-limb disuse produces rapid, front-loaded atrophy. The review also found substantial variation between muscles and warned that repeated short spells of disuse can add to lifetime muscle loss.

Joint replacement patients face more than age. They often contend with surgical inflammation, pain, reduced appetite, limited walking, and restrictions on loaded exercise. The perioperative period therefore acts as a compressed test of the same problem seen in sarcopenia: when activity falls and protein intake is inadequate, muscle becomes easier to lose.

Baseline intake may explain part of the apparent benefit. Khani and colleagues reported that 30.3% to 65.1% of arthroplasty candidates consumed less protein than the 1.2 to 1.6 g/kg/day target cited for older adults in surgical catabolic states. Correcting low intake can produce a meaningful effect without proving that an already well-nourished patient needs a specialized amino acid product. The trials did not report effects separately for participants who began protein-deficient versus those already meeting the target.

Mass is not strength

During immobilization, strength can decline more than muscle cross-sectional area. That gap points toward changes in neuromuscular activation as well as loss of tissue. The available evidence supports that explanation, but it does not establish the exact mechanism in every arthroplasty patient. Pain, swelling, altered movement patterns, and the timing and intensity of physical therapy can all affect a strength test after surgery.

The comparison with sarcopenia trials helps. In a 2023 meta-analysis of whey protein during resistance exercise training, older adults with sarcopenia improved skeletal muscle mass and strength. A 2025 randomized trial of branched-chain-amino-acid-rich supplements plus resistance training in older people with sarcopenia likewise improved body composition and physical function. And a 2024 systematic review and meta-analysis found benefits when community-dwelling older adults with sarcopenia combined protein supplementation with resistance exercise.

These studies do not formally prove that exercise alone explains the arthroplasty meta-analysis's null strength result. The populations, interventions, endpoints, and recovery conditions differ. But the pattern is consistent: protein has a much better chance of improving functional outcomes when resistance training accompanies it. A 2023 systematic review of exercise plus dietary supplementation reached the same broad conclusion for older adults with sarcopenia.

Does the protein source matter?

Leucine has a credible physiological role. A 2023 systematic review by Wilkinson et al. found a dose-response relationship between dietary leucine and post-exercise muscle protein synthesis. The review supports an approximate 2.5 to 3 g leucine threshold per serving, while also noting that older adults show anabolic resistance and may need a larger stimulus. These findings come from post-exercise research, however, not from inflamed post-surgical patients. They should guide formulation choices, not masquerade as a validated postoperative prescription.

Whole food and conventional protein supplements deserve more respect than marketing often gives them. A 2025 meta-analysis of randomized trials by Reid-McCann et al. found broadly comparable effects of plant and animal whole proteins and isolated essential amino acids on muscle mass, strength, physical performance, and sarcopenia outcomes. In chronic sarcopenia care, total protein adequacy and sufficient leucine per meal may matter more than paying a premium for isolated EAAs.

That conclusion has limits in the surgical setting. Five trials in the arthroplasty review used intravenous amino acid infusion, which creates an exposure that outpatient oral products cannot reproduce. The pooled muscle-mass estimate may therefore overstate what an oral prehabilitation protocol can accomplish. The review did not provide a head-to-head pooled comparison of intravenous and oral delivery.

What patients can reasonably do

If joint replacement is planned, discuss nutrition with the surgical team before the operation, especially if appetite, unintentional weight loss, kidney disease, or a restricted diet makes adequate intake difficult. The 1.2 to 1.6 g/kg/day perioperative target cited in the arthroplasty review is a reasonable clinical discussion point for many older adults, not a one-size-fits-all instruction. Kidney disease and other conditions can change the appropriate plan.

Practical priorities are straightforward: identify low protein intake early, spread protein across meals, choose a protein source the patient will actually tolerate, and follow the surgeon's and physical therapist's progression for safe loading. Vitamin D status may also deserve attention. A systematic review and meta-analysis of vitamin D plus protein supplementation found muscle-related benefits in sarcopenia trials, although it cannot show that vitamin D deficiency caused the null strength result in arthroplasty studies.

The evidence supports protein or amino acid supplementation as a way to preserve muscle mass during a high-risk period. It does not support treating nutrition as a substitute for rehabilitation. The unanswered trial is larger and more practical: preoperative versus postoperative-only protein support, stratified by baseline intake, paired with standardized early physiotherapy and lower-limb strength outcomes. Until that study arrives, protein is best viewed as rehabilitation's nutritional support staff, not its replacement.